nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinalukast—CYSLTR1—Endothelins—EDNRA—atherosclerosis	0.0314	0.0314	CbGpPWpGaD
Cinalukast—CYSLTR1—G alpha (q) signalling events—HRH1—atherosclerosis	0.0295	0.0295	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRH1—atherosclerosis	0.0264	0.0264	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—HRH1—atherosclerosis	0.0228	0.0228	CbGpPWpGaD
Cinalukast—CYSLTR1—Endothelins—EDN1—atherosclerosis	0.0227	0.0227	CbGpPWpGaD
Cinalukast—CYSLTR1—Endothelins—PRKCG—atherosclerosis	0.0214	0.0214	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—HRH1—atherosclerosis	0.0195	0.0195	CbGpPWpGaD
Cinalukast—CYSLTR1—Endothelins—MMP1—atherosclerosis	0.019	0.019	CbGpPWpGaD
Cinalukast—CYSLTR1—G alpha (q) signalling events—UTS2—atherosclerosis	0.019	0.019	CbGpPWpGaD
Cinalukast—CYSLTR1—G alpha (q) signalling events—CASR—atherosclerosis	0.0182	0.0182	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—UTS2—atherosclerosis	0.017	0.017	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—CASR—atherosclerosis	0.0163	0.0163	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—HRH1—atherosclerosis	0.0149	0.0149	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CCL4—atherosclerosis	0.0141	0.0141	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—CX3CR1—atherosclerosis	0.0141	0.0141	CbGpPWpGaD
Cinalukast—CYSLTR1—G alpha (q) signalling events—EDNRA—atherosclerosis	0.0132	0.0132	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—CNR2—atherosclerosis	0.0131	0.0131	CbGpPWpGaD
Cinalukast—CYSLTR1—G alpha (q) signalling events—GHRL—atherosclerosis	0.0128	0.0128	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—UTS2—atherosclerosis	0.0126	0.0126	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CX3CR1—atherosclerosis	0.0121	0.0121	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CX3CL1—atherosclerosis	0.0118	0.0118	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—atherosclerosis	0.0118	0.0118	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—atherosclerosis	0.0115	0.0115	CbGpPWpGaD
Cinalukast—CYSLTR1—G alpha (q) signalling events—KNG1—atherosclerosis	0.0113	0.0113	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CNR2—atherosclerosis	0.0112	0.0112	CbGpPWpGaD
Cinalukast—CYSLTR1—G alpha (q) signalling events—AGTR1—atherosclerosis	0.0112	0.0112	CbGpPWpGaD
Cinalukast—CYSLTR1—Endothelins—MAPK8—atherosclerosis	0.0108	0.0108	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—CCL4—atherosclerosis	0.0107	0.0107	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—EDNRA—atherosclerosis	0.0102	0.0102	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—CCR2—atherosclerosis	0.0102	0.0102	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—atherosclerosis	0.0101	0.0101	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—atherosclerosis	0.01	0.01	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CCL3—atherosclerosis	0.00964	0.00964	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—UTS2—atherosclerosis	0.00958	0.00958	CbGpPWpGaD
Cinalukast—CYSLTR1—G alpha (q) signalling events—EDN1—atherosclerosis	0.00949	0.00949	CbGpPWpGaD
Cinalukast—CYSLTR1—Endothelins—MAPK3—atherosclerosis	0.00941	0.00941	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—CASR—atherosclerosis	0.00918	0.00918	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—CX3CR1—atherosclerosis	0.00918	0.00918	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—CX3CL1—atherosclerosis	0.009	0.009	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—atherosclerosis	0.00892	0.00892	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—EDNRA—atherosclerosis	0.00872	0.00872	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CCR2—atherosclerosis	0.00872	0.00872	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—AGTR1—atherosclerosis	0.00865	0.00865	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—CNR2—atherosclerosis	0.00854	0.00854	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—GHRL—atherosclerosis	0.00849	0.00849	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—atherosclerosis	0.00849	0.00849	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—HRH1—atherosclerosis	0.0084	0.0084	CbGpPWpGaD
Cinalukast—CYSLTR1—G alpha (q) signalling events—AGT—atherosclerosis	0.00788	0.00788	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—HRH1—atherosclerosis	0.00763	0.00763	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—KNG1—atherosclerosis	0.00746	0.00746	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—AGTR1—atherosclerosis	0.00741	0.00741	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—CCL3—atherosclerosis	0.00734	0.00734	CbGpPWpGaD
Cinalukast—CYSLTR1—G alpha (q) signalling events—F2—atherosclerosis	0.00728	0.00728	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—atherosclerosis	0.00704	0.00704	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—CCR2—atherosclerosis	0.00664	0.00664	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—EDNRA—atherosclerosis	0.00664	0.00664	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—atherosclerosis	0.00651	0.00651	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—GHRL—atherosclerosis	0.00647	0.00647	CbGpPWpGaD
Cinalukast—CYSLTR1—Endothelins—AKT1—atherosclerosis	0.00635	0.00635	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—EDN1—atherosclerosis	0.00628	0.00628	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CCL5—atherosclerosis	0.00624	0.00624	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—KNG1—atherosclerosis	0.00568	0.00568	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—AGTR1—atherosclerosis	0.00564	0.00564	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—CCL4—atherosclerosis	0.00551	0.00551	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—UTS2—atherosclerosis	0.00541	0.00541	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—AGT—atherosclerosis	0.00522	0.00522	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—CASR—atherosclerosis	0.00519	0.00519	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—UTS2—atherosclerosis	0.00491	0.00491	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—CNR2—atherosclerosis	0.00482	0.00482	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	0.00482	0.00482	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—EDN1—atherosclerosis	0.00479	0.00479	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—CCL5—atherosclerosis	0.00475	0.00475	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—CX3CR1—atherosclerosis	0.00471	0.00471	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—CASR—atherosclerosis	0.00471	0.00471	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—CX3CL1—atherosclerosis	0.00462	0.00462	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—HRH1—atherosclerosis	0.00451	0.00451	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—CNR2—atherosclerosis	0.00438	0.00438	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.0043	0.0043	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—AGT—atherosclerosis	0.00397	0.00397	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—CCL3—atherosclerosis	0.00377	0.00377	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—CCR2—atherosclerosis	0.00375	0.00375	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—EDNRA—atherosclerosis	0.00375	0.00375	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—F2—atherosclerosis	0.00367	0.00367	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—GHRL—atherosclerosis	0.00366	0.00366	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—APOA4—atherosclerosis	0.00354	0.00354	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—atherosclerosis	0.00352	0.00352	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—EDNRA—atherosclerosis	0.00341	0.00341	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—CCR2—atherosclerosis	0.00341	0.00341	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.0034	0.0034	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—GHRL—atherosclerosis	0.00332	0.00332	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—CCL2—atherosclerosis	0.00327	0.00327	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CCL4—atherosclerosis	0.00326	0.00326	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—KNG1—atherosclerosis	0.00321	0.00321	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—AGTR1—atherosclerosis	0.00319	0.00319	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—APOA2—atherosclerosis	0.00304	0.00304	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—KNG1—atherosclerosis	0.00291	0.00291	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—UTS2—atherosclerosis	0.0029	0.0029	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—AGTR1—atherosclerosis	0.0029	0.0029	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CX3CR1—atherosclerosis	0.00278	0.00278	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CASR—atherosclerosis	0.00278	0.00278	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CX3CL1—atherosclerosis	0.00273	0.00273	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—EDN1—atherosclerosis	0.0027	0.0027	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—CCL5—atherosclerosis	0.00268	0.00268	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CNR2—atherosclerosis	0.00259	0.00259	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—CXCL8—atherosclerosis	0.00259	0.00259	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—MMP3—atherosclerosis	0.00258	0.00258	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	0.00258	0.00258	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—PRKCG—atherosclerosis	0.00255	0.00255	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—EDN1—atherosclerosis	0.00246	0.00246	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—CCL5—atherosclerosis	0.00244	0.00244	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—PRKCG—atherosclerosis	0.00232	0.00232	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—VWF—atherosclerosis	0.00231	0.00231	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—APOC3—atherosclerosis	0.00229	0.00229	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—LDLR—atherosclerosis	0.00228	0.00228	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—AGT—atherosclerosis	0.00224	0.00224	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CCL3—atherosclerosis	0.00223	0.00223	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—NCF1—atherosclerosis	0.00213	0.00213	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—F2—atherosclerosis	0.00207	0.00207	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—AGT—atherosclerosis	0.00204	0.00204	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—EDNRA—atherosclerosis	0.00201	0.00201	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CCR2—atherosclerosis	0.00201	0.00201	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CYBA—atherosclerosis	0.002	0.002	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—PIK3CG—atherosclerosis	0.00198	0.00198	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PARP1—atherosclerosis	0.00196	0.00196	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—GHRL—atherosclerosis	0.00196	0.00196	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PLAT—atherosclerosis	0.00196	0.00196	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—F2—atherosclerosis	0.00188	0.00188	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—PIK3CG—atherosclerosis	0.0018	0.0018	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—KNG1—atherosclerosis	0.00172	0.00172	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—AGTR1—atherosclerosis	0.00171	0.00171	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—CCL2—atherosclerosis	0.00168	0.00168	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PLG—atherosclerosis	0.00167	0.00167	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—SOCS3—atherosclerosis	0.00158	0.00158	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—MMP3—atherosclerosis	0.00153	0.00153	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—IGF2—atherosclerosis	0.00152	0.00152	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—APOB—atherosclerosis	0.00147	0.00147	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—CXCL8—atherosclerosis	0.00146	0.00146	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—EDN1—atherosclerosis	0.00145	0.00145	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CCL5—atherosclerosis	0.00144	0.00144	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—LPL—atherosclerosis	0.00141	0.00141	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PRKCG—atherosclerosis	0.00137	0.00137	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—SPP1—atherosclerosis	0.00133	0.00133	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—CXCL8—atherosclerosis	0.00133	0.00133	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PDGFB—atherosclerosis	0.00123	0.00123	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—AGT—atherosclerosis	0.0012	0.0012	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—APOE—atherosclerosis	0.00118	0.00118	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—LEP—atherosclerosis	0.00118	0.00118	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CAV1—atherosclerosis	0.00117	0.00117	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—APOA1—atherosclerosis	0.00117	0.00117	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—ESR1—atherosclerosis	0.00113	0.00113	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—F2—atherosclerosis	0.00111	0.00111	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PIK3CG—atherosclerosis	0.00106	0.00106	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—MAPK3—atherosclerosis	0.00102	0.00102	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—INS—atherosclerosis	0.00101	0.00101	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CCL2—atherosclerosis	0.000992	0.000992	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—IGF1—atherosclerosis	0.000975	0.000975	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—SERPINE1—atherosclerosis	0.000926	0.000926	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—NOS3—atherosclerosis	0.000884	0.000884	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CXCL8—atherosclerosis	0.000784	0.000784	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—AKT1—atherosclerosis	0.000757	0.000757	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—IL6—atherosclerosis	0.000746	0.000746	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—MMP9—atherosclerosis	0.000709	0.000709	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—NFKB1—atherosclerosis	0.000702	0.000702	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—MAPK8—atherosclerosis	0.00069	0.00069	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—AKT1—atherosclerosis	0.000688	0.000688	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—VEGFA—atherosclerosis	0.000637	0.000637	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—STAT3—atherosclerosis	0.00063	0.00063	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—MAPK3—atherosclerosis	0.000602	0.000602	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—TGFB1—atherosclerosis	0.000584	0.000584	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—IL6—atherosclerosis	0.00044	0.00044	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—AKT1—atherosclerosis	0.000406	0.000406	CbGpPWpGaD
